Skip Navigation
Skip to contents

JLC : Journal of Liver Cancer

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Liver Cancer > Volume 16(2); 2016 > Article
Review Article Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis
Jin Su Kim, Su Cheol Park
Journal of Liver Cancer 2016;16(2):82-85
DOI: https://doi.org/10.17998/jlc.16.2.82
Published online: September 30, 2016
Department of Internal Medicine, Korea Cancer Center Hospital, Korean Institute of Radiological and Medical Sciences, Seoul, Korea
Corresponding author:  Su Cheol Park,
Email: hepapark@kcch.re.kr
  • 1,338 Views
  • 15 Download
  • 0 Crossref
  • 0 Scopus

Transarterial chemoembolization (TACE) has been widely performed as a treatment for unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC is increasing due to improvement of survival. Sorafenib has been generally accepted as a standard treatment in advanced HCC. However, many HCC patients with EHM are treated with TACE in real-world clinical practice because sorafenib has modest efficacy and the main cause of death in the patients with EHM is hepatic failure. In this review, the usefulness of TACE for the patients with HCC and EHM will be discussed.


JLC : Journal of Liver Cancer